A practical checklist for evaluating decentralized trial technology vendors, built from an RF engineer’s view of where data quality actually breaks.
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Transformative Role Of Digital Health Technologies
Digital health technologies are transforming clinical trials through decentralization, improved data, and patient-centric approaches, driving efficiency and accessibility.
-
Email: The Gold Standard For Clinical Trials
Although non-verbal conversations between friends are now primarily conducted through text messages or similar apps, see why email remains the standard mode for businesses and organizations.
-
Reclaiming Your Time: How Sponsors Can Save Thousands Of Hours With Agentic AI
Reimagine the clinical trial lifecycle by automating slow, manual workflows, removing barriers in the clinical process, and introducing new ways to achieve R&D goals like never before.
-
Why Real-Time eCOA Data Matters More Than Ever
Real-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.
-
Evaluating Wearable Data Platforms For Endpoint-Driven Studies
Endpoint‑driven studies need platforms that unify wearable data with trial systems, support derived measures, and ensure traceability so continuous data becomes reliable clinical evidence.
-
Rewriting The Rules Of Clinical Trials Through Digital Biomarkers
Digital biomarkers are reshaping clinical research with continuous, real‑world data. Explore how emerging tools, AI, and cross‑industry collaboration are driving smarter clinical development.
-
How To Use Real World Data To Maximize Patient Recruitment In DCTs
In the clinical trial space, RWD helps support research design, protocol and patient engagement goals. Perhaps the most immediate way clinical research leaders can harness the power of RWD is as a tool for optimized patient recruitment. Learn how this can be done in the available blog.
-
Repositioning Your CDM Team To Meet Digital Trial Demands
Consider these steps when repositioning your clinical data management team to unify cross-functional reviews and align processes and technology to meet the demands of digital trials.
-
The Language Of eCOAs
In this article, learn more about COAs, and their electronic counterparts, eCOAs.
-
Comparative Effectiveness Of eConsent: Systematic Review
This blog post examines eConsent vs. ICF on comprehension, acceptability, enrollment, retention, consent time, and site workload.
RECENT NEWSLETTERS
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech